These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6982230)

  • 1. Comparative role of complement in pneumococcal and staphylococcal pneumonia.
    Coonrod JD; Yoneda K
    Infect Immun; 1982 Sep; 37(3):1270-7. PubMed ID: 6982230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role of complement in the development of experimental pneumococcal pneumonia in mice.
    Nakajima R; Namba K; Ishida Y; Une T; Osada Y
    Chemotherapy; 1990; 36(4):287-93. PubMed ID: 2147644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cirrhosis-induced defects in innate pulmonary defenses against Streptococcus pneumoniae.
    Propst-Graham KL; Preheim LC; Vander Top EA; Snitily MU; Gentry-Nielsen MJ
    BMC Microbiol; 2007 Oct; 7():94. PubMed ID: 17956621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of opsonins in recovery from experimental pneumococcal pneumonia.
    Guckian JC; Christensen GD; Fine DP
    J Infect Dis; 1980 Aug; 142(2):175-90. PubMed ID: 6997403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early clearance of pneumococci from the lungs of decomplemented rats.
    Rehm SR; Coonrod JD
    Infect Immun; 1982 Apr; 36(1):24-9. PubMed ID: 7076296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia.
    Rubins JB; Charboneau D; Paton JC; Mitchell TJ; Andrew PW; Janoff EN
    J Clin Invest; 1995 Jan; 95(1):142-50. PubMed ID: 7814608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal pneumonia in a rat model of cirrhosis: effects of cirrhosis on pulmonary defense mechanisms against Streptococcus pneumoniae.
    Mellencamp MA; Preheim LC
    J Infect Dis; 1991 Jan; 163(1):102-8. PubMed ID: 1984456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model of pneumococcal pneumonia in chronically intoxicated rats.
    Davis CC; Mellencamp MA; Preheim LC
    J Infect Dis; 1991 Apr; 163(4):799-805. PubMed ID: 2010633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung bacterial clearance in murine pneumococcal pneumonia.
    Ansfield MJ; Woods DE; Johanson WG
    Infect Immun; 1977 Jul; 17(1):195-204. PubMed ID: 18404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary opsonins in Klebsiella pneumoniae pneumonia in rats.
    Coonrod JD
    Infect Immun; 1981 Aug; 33(2):533-9. PubMed ID: 7024132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3.
    Kerr AR; Paterson GK; Riboldi-Tunnicliffe A; Mitchell TJ
    Infect Immun; 2005 Jul; 73(7):4245-52. PubMed ID: 15972516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement and opsonins in alveolar secretions and serum of rats with pneumonia due to Streptococcus pneumoniae.
    Coonrod JD; Yoneda K
    Rev Infect Dis; 1981; 3(2):310-22. PubMed ID: 7256089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads.
    Sawai T; Tomono K; Yanagihara K; Yamamoto Y; Kaku M; Hirakata Y; Koga H; Tashiro T; Kohno S
    Infect Immun; 1997 Feb; 65(2):466-71. PubMed ID: 9009298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas/Fas ligand system mediates epithelial injury, but not pulmonary host defenses, in response to inhaled bacteria.
    Matute-Bello G; Frevert CW; Liles WC; Nakamura M; Ruzinski JT; Ballman K; Wong VA; Vathanaprida C; Martin TR
    Infect Immun; 2001 Sep; 69(9):5768-76. PubMed ID: 11500454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-18 improves the early antimicrobial host response to pneumococcal pneumonia.
    Lauw FN; Branger J; Florquin S; Speelman P; van Deventer SJ; Akira S; van der Poll T
    J Immunol; 2002 Jan; 168(1):372-8. PubMed ID: 11751983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection.
    van der Sluijs KF; van Elden LJ; Nijhuis M; Schuurman R; Pater JM; Florquin S; Goldman M; Jansen HM; Lutter R; van der Poll T
    J Immunol; 2004 Jun; 172(12):7603-9. PubMed ID: 15187140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of complement in the localization of pneumococci in the splanchnic reticuloendothelial system during experimental bacteremia.
    Brown EJ; Hosea SW; Frank MM
    J Immunol; 1981 Jun; 126(6):2230-5. PubMed ID: 7229372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endothelial protein C receptor impairs the antibacterial response in murine pneumococcal pneumonia and sepsis.
    Schouten M; de Boer JD; Kager LM; Roelofs JJ; Meijers JC; Esmon CT; Levi M; van 't Veer C; van der Poll T
    Thromb Haemost; 2014 May; 111(5):970-80. PubMed ID: 24401906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae.
    Szalai AJ; Briles DE; Volanakis JE
    Infect Immun; 1996 Nov; 64(11):4850-3. PubMed ID: 8890251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the nature of bacteremia in experimental pneumococcal pneumonia in the dog. II. Disappearance of pneumococci from the circulation in relation to the bactericidal action of the blood in vitro.
    GREGG LA; ROBERTSON OH
    J Exp Med; 1953 Feb; 97(2):297-314. PubMed ID: 13022880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.